BRUSSELS, BELGIUM / RankWire.AI / – The European Commission has committed to acquiring €2.1 million worth of PCR tests to support the ongoing Bundibugyo Ebola outbreak. These open-platform diagnostics will aid in infection detection and bolster laboratory capabilities during this emergency, with procurement arrangements made with assistance from the European Health and Digital Executive Agency. Distribution of supplies is scheduled to start in August, supplementing existing diagnostic resources as health authorities confront increasing case counts in the Democratic Republic of the Congo.
The PCR testing kits will be sent to the World Health Organization’s Hub for Global Health Emergencies Logistics in Dubai, which will oversee their distribution to regions engaged in Ebola response efforts. PCR testing is vital for confirming infections, as laboratories can analyze large volumes of samples with high precision. The testing equipment is compatible with current laboratory infrastructure, enabling rapid confirmation of cases. This expedites patient identification, facilitates suitable treatment and isolation procedures, and supports contact tracing for confirmed cases.
This procurement effort follows a separate agreement by the European Commission for €2.5 million in rapid molecular point-of-care tests and testing devices. These supplies are intended for the Africa Centres for Disease Control and Prevention. Combined, these initiatives bring the European Commission’s total diagnostic support to €4.6 million. Such measures form part of a broader European response to the Bundibugyo virus crisis, which has increasingly strained health systems in affected regions of Central and East Africa.
Diagnostic expansion accompanies outbreak escalation
By August 12, WHO reported that the Democratic Republic of the Congo had confirmed 4,665 cases and recorded 2,184 deaths. The outbreak has affected 54 health zones across six provinces, including Ituri, North Kivu, South Kivu, Haut-Uélé, Tshopo and Bas-Uélé. WHO described this as the largest Ebola outbreak ever documented in the country, highlighting persistent intense transmission and interconnected geographic clusters that continue to facilitate the spread within affected areas.
On August 14, WHO maintained its highest national risk classification for the Democratic Republic of the Congo. The regional risk for neighboring nations was assessed as high, while the threat to other countries was deemed low. The agency issued updated temporary guidelines on August 24 following a second meeting of its International Health Regulations Emergency Committee. These recommendations address surveillance, case detection, infection prevention, clinical management, community engagement, and measures related to domestic mobility and mass gatherings.
European aid efforts total €493 million and continue to expand
The European Commission has allocated €493 million to support emergency response, vaccination campaigns, treatment initiatives, and health security measures across the Great Lakes and Uganda regions. European health authorities have also contributed to surveillance, laboratory testing, and preparedness activities throughout the outbreak. The European Centre for Disease Prevention and Control continues to evaluate the risk to European populations as very low, based on the low likelihood of sustained transmission and the need for direct contact with infectious body fluids.
The Bundibugyo outbreak remains classified as a public health emergency of international concern, a designation declared by WHO on May 17. Unlike the more prevalent Zaire ebolavirus, there is currently no approved vaccine or specific treatment for Bundibugyo virus. WHO emphasizes ongoing surveillance, rapid diagnosis, case isolation, clinical management, infection control, and contact monitoring as key responses. The latest PCR procurement by the European Commission enhances laboratory capacity to support these measures, with WHO and Africa CDC coordinating health operations alongside national authorities in affected and neighboring regions.